Technical Analysis for AXGN - AxoGen, Inc.

Grade Last Price % Change Price Change
grade A 11.8 1.46% 0.17
AXGN closed up 1.46 percent on Friday, September 25, 2020, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical AXGN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
200 DMA Support Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Fell Below 20 DMA Bearish 1.46%
Fell Below 50 DMA Bearish 1.46%
200 DMA Support Bullish 1.46%
New Uptrend Bullish -2.64%
Older End-of-Day Gignals for AXGN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Resistance about 19 hours ago
Up 2% about 19 hours ago
Rose Above 20 DMA about 19 hours ago
Rose Above 50 DMA about 20 hours ago
200 DMA Support about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

AxoGen, Inc. operates as a regenerative medicine company. It focuses on advancing the science and commercialization of peripheral nerve repair solutions. It offers a range of surgical nerve reconstruction solutions, including Avance Nerve Graft, a processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa ExtraCellular Matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. The company's products are used by surgeons during surgical interventions to repair traumatic nerve injuries. It procures and processes its tissue products in the United States and markets in the United States, Canada, Switzerland, Austria, and Italy. AxoGen, Inc. is headquartered in Alachua, Florida.
Organ Systems Regenerative Medicine Neurosurgery Nervous System Surgical Site Tissue Products

Is AXGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.84
52 Week Low 7.16
Average Volume 296,181
200-Day Moving Average 11.53
50-Day Moving Average 11.67
20-Day Moving Average 11.82
10-Day Moving Average 12.03
Average True Range 0.73
ADX 25.65
+DI 29.42
-DI 16.98
Chandelier Exit (Long, 3 ATRs ) 11.69
Chandelier Exit (Short, 3 ATRs ) 12.59
Upper Bollinger Band 13.16
Lower Bollinger Band 10.48
Percent B (%b) 0.49
BandWidth 22.64
MACD Line 0.18
MACD Signal Line 0.17
MACD Histogram 0.0085
Fundamentals Value
Market Cap 392.23 Million
Num Shares 33.2 Million
EPS -0.43
Price-to-Earnings (P/E) Ratio -27.44
Price-to-Sales 13.36
Price-to-Book 58.94
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.42
Resistance 3 (R3) 12.39 12.17 12.31
Resistance 2 (R2) 12.17 12.01 12.18 12.28
Resistance 1 (R1) 11.98 11.91 12.08 12.01 12.24
Pivot Point 11.76 11.76 11.80 11.77 11.76
Support 1 (S1) 11.57 11.60 11.67 11.60 11.36
Support 2 (S2) 11.35 11.50 11.36 11.32
Support 3 (S3) 11.16 11.35 11.29
Support 4 (S4) 11.19